Food and Drug Administration officials say they will review the safety of three anemia drugs after research linked one of the drugs to strokes.
The medications include Johnson & Johnson's Procrit, and Amgen's Epogen and Aranesp.
The clinical trial from 2004 involved diabetic and kidney disease patients taking...
more »